Literature DB >> 2555556

The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

M Katzman1, R A Katz, A M Skalka, J Leis.   

Abstract

The purified integration protein (IN) of avian myeloblastosis virus is shown to nick double-stranded oligodeoxynucleotide substrates that mimic the ends of the linear form of viral DNA. In the presence of Mg2+, nicks are created 2 nucleotides from the 3' OH ends of both the U5 plus strand and the U3 minus strand. Similar cleavage is observed in the presence of Mn2+ but only when the extent of the reaction is limited. Neither the complementary strands nor sequences representing the termini of human immunodeficiency virus type 1 DNA were cleaved at analogous positions. Analysis of a series of substrates containing U5 base substitutions has defined the sequence requirements for site-selective nicking; nucleotides near the cleavage site are most critical for activity. The minimum substrate size required to demonstrate significant activity corresponds to the nearly perfect 15-base terminal inverted repeat. This in vitro activity of IN thus produces viral DNA ends that are joined to host DNA in vivo and corresponds to an expected early step in the integrative recombination reaction. These results provide the first enzymatic support using purified retroviral proteins for a linear DNA precursor to the integrated provirus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555556      PMCID: PMC251198          DOI: 10.1128/JVI.63.12.5319-5327.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity.

Authors:  D P Grandgenett; A C Vora; R D Schiff
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

2.  Analysis of unintegrated avian RNA tumor virus double-stranded DNA intermediates.

Authors:  T W Hsu; J L Sabran; G E Mark; R V Guntaka; J M Taylor
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

3.  Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA.

Authors:  P R Shank; S H Hughes; H J Kung; J E Majors; N Quintrell; R V Guntaka; J M Bishop; H E Varmus
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

4.  Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites.

Authors:  S H Hughes; P R Shank; D H Spector; H J Kung; J M Bishop; H E Varmus; P K Vogt; M L Breitman
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

5.  RNA-dependent DNA polymerase activity of RNA tumor viruses. I. Directing influence of DNA in the reaction.

Authors:  J Hurwitz; J P Leis
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

6.  Studies on the reverse transcriptase of RNA tumor viruses. Structural relatedness of two subunits of avian RNA tumor viruses.

Authors:  W Gibson; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Sequence relatedness between the subunits of avian myeloblastosis virus reverse transcriptase.

Authors:  H M Rho; D P Grandgenett; M Green
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

8.  Virus-coded origin of a 32,000-dalton protein from avian retrovirus cores: structural relatedness of p32 and the beta polypeptide of the avian retrovirus DNA polymerase.

Authors:  R D Schiff; D P Grandgenett
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

9.  Endonuclease activity of purified RNA-directed DNA polymerase from avian myeloblastosis virus.

Authors:  M Golomb; D P Grandgenett
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

10.  RNA-dependent DNA polymerase activity of RNA tumor virus. VI. Processive mode of action of avian myeloblastosis virus polymerase.

Authors:  J P Leis
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

View more
  161 in total

Review 1.  Retroviral DNA integration.

Authors:  P Hindmarsh; J Leis
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  Substrate sequence selection by retroviral integrase.

Authors:  H Zhou; G J Rainey; S K Wong; J M Coffin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation.

Authors:  Y Hwang; D Rhodes; F Bushman
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

4.  Repair of gaps in retroviral DNA integration intermediates.

Authors:  K E Yoder; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Retroviral cDNA integration: stimulation by HMG I family proteins.

Authors:  L Li; K Yoder; M S Hansen; J Olvera; M D Miller; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.

Authors:  Iris Oz; Orna Avidan; Amnon Hizi
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

7.  Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.

Authors:  K Gao; S L Butler; F Bushman
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

8.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

9.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

10.  Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.

Authors:  H Chen; A Engelman
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.